checkAd

     159  0 Kommentare Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer - Seite 3

    Media Contact: Jared Maxwell Investor Contact: Scott Gleason
      (801) 505-5027   (801) 584-1143
      jmaxwell@myriad.com   sgleason@myriad.com


    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer - Seite 3 SALT LAKE CITY, July 31, 2020 (GLOBE NEWSWIRE) - Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that Medicare has expanded coverage for BRACAnalysis CDx for men with prostate cancer …

    Schreibe Deinen Kommentar

    Disclaimer